Skip to main content
logo
NFL Biosciences SA (EPA:ALNFL)
France flag France · Delayed Price · Currency is EUR
0.8790
+0.0090 (1.03%)
Aug 3, 2026, 4:18 PM CET

NFL Biosciences Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0000.200
Revenue Growth
14.63%308.70%-99.98%909040.91%-43.59%1200.00%
Gross Profit
-2.52-2.52-1.55-3.28-2.24-0.53
Operating Income
-3.87-3.87-2.79-4.23-3.08-0.9
Net Income
-3.32-3.32-2.08-3.75-2.44-0.98
Earnings Per Share
-0.26-0.26-0.21-0.46-0.47-0.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.22.22.112.531.213.2
Total Debt
0.580.580.040.060.080.09
Net Cash (Debt)
1.621.622.072.471.133.12
Net Cash Growth
--21.86%-16.00%118.12%-63.74%1285.36%
Net Cash Per Share
0.120.120.210.300.220.60

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-2059909.04%-2059909.04%-6065415.22%-2115.09%-14014404.54%-2312479.49%
Pretax Margin
-2051992.55%-2051992.55%-5904889.13%-2055.82%-13005968.18%-2870535.90%
Profit Margin
-1764876.06%-1764876.06%-4523563.04%-1872.63%-11106745.46%-2508315.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
58642.8279403.73415647.0058.37467546.05322129.97